I only wish I had some inside knowledge then maybe I'd not have loaded up at higher prices than we've seen the past week.

If you go back months you'll see I have always been rather conservative in valuation of Noront. That means my valuation has gone higher as DE1 drill/assays were released AND DE2 identified. I'm not that far off Genuity valuation although feel they are light on value DE2 and certainly DE3 brings to the table.

The market has seemed happy to value Windfall and holdings outside the ROF at $1 per share, DE1 has a drill defined value, in my opinion of at least $4 but that's not including assay values for Rhodium/PGMS (in my opinion). So my feeling is rock bottom of $5 with little to no 'Blue Sky'.

So Noront investment appears, again to me, to have little to no risk at $5. Now if news today backed by assays/drilling etc. shows the market that DE1 has increased valuation the share price should move over $5. IF in addition enough information is released to put a tentative value on DE2 then that should logically take price up another notch, in my opinion $6+. So all it should take to push over $7 is either information solid enough to put higher value on DE2 OR that DE3 has been found and so early idea of size/composition.

Obviously this is all back of the envelope calculation and again based on a guess as to how the Market may value NORONT as a speculative investment. You and I know full well that investors want to pay $6 for something they think is worth $12 and my valuation of DE1/2/3 and Windfall is done that way because I do believe the package, with a little more assay/drill news actually is worth in excess of $12/share.